Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/123975
Title: Cancer, Epigenetics And The Nobel Prizes
Author: Esteller, Manel
Keywords: Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
Issue Date: 1-Dec-2012
Publisher: Elsevier Sci Ltd
Abstract: The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be bestowed with such a prestigious award for their seminal discoveries in the area. However, we can also consider this annual prize as a recognition to Epigenetics, similarly to the Nobel Prize of 2006 for Andrew Z. Fire and Craig C. Mello for their of RNA interference - gene silencing by doublestranded RNA. Reprogramming requires changing the epigenome of the cells and non-coding RNAs are critical elements in the establishment of epigenetic patterns
Note: Reproducció del document publicat a: https://doi.org/10.1016/j.molonc.2012.10.004
It is part of: Molecular Oncology, 2012, Vol. 6, Issue 6, p. 565-566
URI: http://hdl.handle.net/2445/123975
Related resource: https://doi.org/10.1016/j.molonc.2012.10.004
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
EstellerM.pdf150.73 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.